Jiangsu Hengrui Medicine Co Ltd
600276 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic
48.07CNY+0.14 (+0.29%)
Price History
Full chartMarket Stats
Previous Close47.93
Open47.42
Day Range47.38 – 48.37
52-Week Range41.89 – 71.66
Volume38.58M
Market Cap313.28B
P/E (TTM)40.69
Forward P/E59.52
EPS1.16
Dividend Yield0.38%
Beta0.04
50-Day Avg48.97
200-Day Avg53.82
About
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Piao Yang Sun
- Employees20.60K
- HeadquartersNo. 38, Huanghe Road, Lianyungang, China, 222047, China
- Websitehttps://www.hengrui.com
Leadership
- Mr. Piao Yang SunExecutive Chairman of the Board · b. 1958
- Ms. Ji FengGM, President, COO & Executive Director · b. 1972
- Mr. Hong Bin DaiExecutive Deputy Chairman of the Board · b. 1976
- Mr. Jie Ping SunSenior VP & Executive Director · b. 1970
- Dr. Lian Shan Zhang Ph.D.Executive VP & Executive Director · b. 1962
- Dr. Ningjun Jiang M.D., Ph.D.Executive VP, Chief Strategy Officer & Executive Director · b. 1961
- Mr. Guoxin ZhuSenior Vice President
- Ms. Xiao Han LiuBoard Secretary · b. 1985
- Mr. Kin Chun LauChief Financial Officer · b. 1979
- Jia Gang WuAccounting Supervisor
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap313.28B
Enterprise Value262.39B
Trailing P/E40.69
Forward P/E59.52
PEG Ratio0.93
Price / Sales9.62
Price / Book4.69
EPS1.16
Book Value9.38
Revenue (TTM)32.56B
Gross Profit (TTM)28.09B
EBITDA9.45B
Profit Margin24.93%
Operating Margin31.57%
Return on Equity14.54%
Return on Assets8.80%
Shares Outstanding6.38B
Shares Float3.77B
Beta0.04
Dividend Yield0.38%
Dividend Rate0.20
Payout Ratio16.39%
Dividends
20231×
0.16Jun 8, 2023
20221×
0.16Jul 5, 2022
20211×
0.20Jun 10, 2021
20201×
0.19May 25, 2020
20191×
0.15Mar 28, 2019
20181×
0.08May 30, 2018
20171×
0.06May 31, 2017
20161×
0.04Jun 16, 2016
20151×
0.03Jun 15, 2015
20141×
0.02May 15, 2014
20131×
0.02Jun 7, 2013
20121×
0.02May 29, 2012
20111×
0.02Apr 26, 2011
20101×
0.01Mar 17, 2010
20091×
0.01Apr 30, 2009
20081×
0.01Apr 11, 2008
20071×
0.01Apr 2, 2007
20062×
0.01Jul 18, 20060.22Jun 19, 2006
20051×
0.01Jun 16, 2005
20041×
0.00May 28, 2004
20031×
0.00Aug 7, 2003
20021×
0.00May 21, 2002
20011×
0.00May 11, 2001
Stock Splits
- Jun 10, 20216:5
- May 25, 20206:5
- Mar 28, 20196:5
- May 30, 201813:10
- May 31, 20176:5
- Jun 16, 20166:5
- Jun 15, 201513:10
- May 15, 201411:10
- Jun 7, 201311:10
- May 29, 201211:10
- Apr 26, 20113:2
- Mar 17, 20106:5
- Apr 30, 20096:5
- Apr 11, 20086:5
- Apr 2, 200713:10
- Aug 29, 200613:10
- May 21, 20026:5
- May 11, 20018:5